Serum IgA levels induced by rotavirus natural infection, but not following immunization with the RRV-TV vaccine (Rotashield™), correlate with protection

被引:15
作者
González, R
Franco, M
Sarmiento, L
Romero, M
Schael, IP
机构
[1] Cent Univ Venezuela, Inst Biomed Fuvesin, Secc Invest Enfermedades Entericas Infancia, Minist Salud & Desarrollo Social, Caracas 1010A, Venezuela
[2] Pontificia Univ Javeriana, Inst Genet Humana, Bogota, Colombia
[3] Cent Univ Venezuela, Inst Inmunol, Postgrado Inmunol Clin, Minist Salud & Desarrollo Social, Caracas 1010A, Venezuela
[4] Ciudad Hosp Dr Enrique Tejera CHET, Valencia, Estado Carabobo, Venezuela
基金
英国医学研究理事会;
关键词
diarrhea; immune response;
D O I
10.1002/jmv.20404
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
To directly compare serum rotavirus specific IgA as a marker of protection in children vaccinated with the RRV-TV (Rotashield (TM)) vaccine and in naturally infected children, we studied preexisting rotavirus IgA antibodies by ELISA assays in these groups of children within the first 5 days after the onset of a diarrhea episode, due or not to rotavirus. In immunized children, rotavirus IgA titers were similar between infected and non-RV infected children. In non-immunized children, the proportion with rotavirus IgA titers was significantly greater in non-RV infected children (58%) than in infected children (31%). Additionally, a titer >= 1:800 was associated with 68% protection. Thus, in this study serum rotavirus IgA showed a good correlation with protection in children pre-exposed to natural infection but not in those immunized with the RRV-TV vaccine. (c) 2005 Wiley-Liss, Inc.
引用
收藏
页码:608 / 612
页数:5
相关论文
共 26 条
[21]   Rotavirus infection in infants as protection against subsequent infections [J].
Velazquez, FR ;
Matson, DO ;
Calva, JJ ;
Guerrero, ML ;
Morrow, AL ;
CarterCampbell, S ;
Glass, RI ;
Estes, MK ;
Pickering, LK ;
RuizPalacios, GM .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (14) :1022-1028
[22]   Serum antibody as a marker of protection against natural rotavirus infection and disease [J].
Velázquez, FR ;
Matson, DO ;
Guerrero, ML ;
Shults, J ;
Calva, JJ ;
Morrow, AL ;
Glass, RI ;
Pickering, LK ;
Ruiz-Palacios, GM .
JOURNAL OF INFECTIOUS DISEASES, 2000, 182 (06) :1602-1609
[23]   CLINICAL EFFICACY OF THE RIT-4237 LIVE ATTENUATED BOVINE ROTAVIRUS VACCINE IN INFANTS VACCINATED BEFORE A ROTAVIRUS EPIDEMIC [J].
VESIKARI, T ;
ISOLAURI, E ;
DELEM, A ;
DHONDT, E ;
ANDRE, FE ;
BEARDS, GM ;
FLEWETT, TH .
JOURNAL OF PEDIATRICS, 1985, 107 (02) :189-194
[24]   Possible mechanisms of protection elicited by candidate rotavirus vaccines as determined with the adult mouse model [J].
Ward, RL .
VIRAL IMMUNOLOGY, 2003, 16 (01) :17-24
[25]   LACK OF CORRELATION BETWEEN SERUM ROTAVIRUS ANTIBODY-TITERS AND PROTECTION FOLLOWING VACCINATION WITH REASSORTANT RRV VACCINES [J].
WARD, RL ;
BERNSTEIN, DI .
VACCINE, 1995, 13 (13) :1226-1232
[26]   Serologic correlates of immunity in a tetravalent reassortant rotavirus vaccine trial [J].
Ward, RL ;
Knowlton, DR ;
Zito, ET ;
Davidson, BL ;
Rappaport, R ;
Mack, ME .
JOURNAL OF INFECTIOUS DISEASES, 1997, 176 (03) :570-577